Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs

AdvaMed® Advancements: Q1 2025 Report

AdvaMed’s Q1 2025 report focuses on tariffs, policy action, and how we’re protecting Medtech innovation.

Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs

AdvaMed® Statement on Today’s Tariff Announcement

Washington, D.C.– AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker: “Our country is the birthplace of the medical device and technology industry and leads the…

Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Regulatory Affairs / Small Business

AdvaMed®’s Medical Innovation Agenda for the 119th Congress

AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.